Instructions for Use, MOUNJARO (tirzepatide) injection
The drug is administered as a once-weekly subcutaneous injection, similar in delivery to other agents in its class
Currie CJ, Berni ER, Berni TR, Jenkins-Jones S, Sinsakul M, Jermutus L, et al
Discussion The population pharmacokinetic model reported here successfully describes the pharmacokinetics of semaglutide, reproducing the values for CL/F and V/F of approximately 0.05 l/h and 12.5 l, respectively, obtained from clinical pharmacology trials with richly sampled PK profiles in subjects with T2DM (Novo Nordisk, data on file)
Fulfillment timing after approval, which depends on pharmacy processing Willow does not control